Analysis | Metabolite Name | Measured Value | Units | Drug combination | 13C-label position in pyruvate |
---|---|---|---|---|---|
ESI/QTOF negative ion mode | Lactate | Peak area | Isoproterenol | C1 | |
ESI/QTOF negative ion mode | Lactate | Peak area | Isoproterenol | C2 | |
ESI/QTOF negative ion mode | Lactate | Peak area | Isoproterenol + Leelamine | C1 | |
ESI/QTOF negative ion mode | Lactate | Peak area | Isoproterenol + Leelamine | C2 | |
ESI/QTOF negative ion mode | Lactate | Peak area | None | C1 | |
ESI/QTOF negative ion mode | Lactate | Peak area | None | C2 | |
ESI/QTOF negative ion mode | Lactate | Peak area | Rosiglitazone | C1 | |
ESI/QTOF negative ion mode | Lactate | Peak area | Rosiglitazone | C2 | |
ESI/QTOF negative ion mode | Lactate | Peak area | Rosiglitazone + Leelamine | C1 | |
ESI/QTOF negative ion mode | Lactate | Peak area | Rosiglitazone + Leelamine | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_1 | Peak area | Isoproterenol | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_1 | Peak area | Isoproterenol | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_1 | Peak area | Isoproterenol + Leelamine | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_1 | Peak area | Isoproterenol + Leelamine | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_1 | Peak area | None | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_1 | Peak area | None | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_1 | Peak area | Rosiglitazone | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_1 | Peak area | Rosiglitazone | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_1 | Peak area | Rosiglitazone + Leelamine | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_1 | Peak area | Rosiglitazone + Leelamine | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_2 | Peak area | Isoproterenol | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_2 | Peak area | Isoproterenol | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_2 | Peak area | Isoproterenol + Leelamine | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_2 | Peak area | Isoproterenol + Leelamine | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_2 | Peak area | None | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_2 | Peak area | None | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_2 | Peak area | Rosiglitazone | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_2 | Peak area | Rosiglitazone | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_2 | Peak area | Rosiglitazone + Leelamine | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_2 | Peak area | Rosiglitazone + Leelamine | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_3 | Peak area | Isoproterenol | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_3 | Peak area | Isoproterenol | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_3 | Peak area | Isoproterenol + Leelamine | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_3 | Peak area | Isoproterenol + Leelamine | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_3 | Peak area | None | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_3 | Peak area | None | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_3 | Peak area | Rosiglitazone | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_3 | Peak area | Rosiglitazone | C2 | |
ESI/QTOF negative ion mode | Lactate_13C_3 | Peak area | Rosiglitazone + Leelamine | C1 | |
ESI/QTOF negative ion mode | Lactate_13C_3 | Peak area | Rosiglitazone + Leelamine | C2 |